ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the firm has initiated outlook for the full-year 2025.
Excluding items, for the full-year 2024, the company still expects earnings per share of $13.90 to $14.10, with revenue of $8.260 billion to $8.300 billion.
For the full year to December 31, the company expects adjusted earnings per share of $13 to $15, on revenue of $8.050 billion to $8.650 billion. This guidance excludes any potential share repurchase or additional merger and acquisition activity.
Steve Cutler, CEO of ICON Plc, said: "Our outlook for this year reflects an expected transition period which includes a headwind from our top two customers on a combined basis, coupled with an inconsistent recovery in biotech. This is being partially offset by growth in strategic partnerships that are expected to contribute to our results as we progress through the year."
ICLR was down by 9.12 percent at $198.10 in the pre-market trade on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.